These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20655707)

  • 41. Genetic and Pharmacological Targeting of Heat Shock Protein 70 in the Mouse Amygdala-Kindling Model.
    von Rüden EL; Wolf F; Gualtieri F; Keck M; Hunt CR; Pandita TK; Potschka H
    ACS Chem Neurosci; 2019 Mar; 10(3):1434-1444. PubMed ID: 30396268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension.
    Avendaño MS; Martínez-Revelles S; Aguado A; Simões MR; González-Amor M; Palacios R; Guillem-Llobat P; Vassallo DV; Vila L; García-Puig J; Beltrán LM; Alonso MJ; Cachofeiro MV; Salaices M; Briones AM
    Br J Pharmacol; 2016 May; 173(9):1541-55. PubMed ID: 26856544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostaglandin E2 EP1 receptor inhibition fails to provide neuroprotection in surgically induced brain-injured mice.
    Khatibi NH; Jadhav V; Matus B; Fathali N; Martin R; Applegate R; Tang J; Zhang JH
    Acta Neurochir Suppl; 2011; 111():277-81. PubMed ID: 21725768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.
    Wendt H; Soerensen J; Wotjak CT; Potschka H
    Epilepsia; 2011 Jul; 52(7):e62-5. PubMed ID: 21627644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.
    Surh I; Rundhaug JE; Pavone A; Mikulec C; Abel E; Simper M; Fischer SM
    Mol Carcinog; 2012 Jul; 51(7):553-64. PubMed ID: 21739481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis.
    Miki T; Matsunami M; Nakamura S; Okada H; Matsuya H; Kawabata A
    Pain; 2011 Jun; 152(6):1373-1381. PubMed ID: 21396778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis.
    Chen X; Yin J; Xu Y; Qiu Z; Liu J; Chen X
    Mol Med Rep; 2020 Oct; 22(4):2887-2895. PubMed ID: 32700746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway.
    Zhou P; Qian L; Chou T; Iadecola C
    Neurobiol Dis; 2008 Mar; 29(3):543-51. PubMed ID: 18178094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.
    Kawano T; Anrather J; Zhou P; Park L; Wang G; Frys KA; Kunz A; Cho S; Orio M; Iadecola C
    Nat Med; 2006 Feb; 12(2):225-9. PubMed ID: 16432513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists.
    Allan AC; Billinton A; Brown SH; Chowdhury A; Eatherton AJ; Fieldhouse C; Giblin GM; Goldsmith P; Hall A; Hurst DN; Naylor A; Rawlings DA; Sime M; Scoccitti T; Theobald PJ
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4343-8. PubMed ID: 21676612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer.
    O'Callaghan G; Ryan A; Neary P; O'Mahony C; Shanahan F; Houston A
    Int J Cancer; 2013 Aug; 133(4):825-34. PubMed ID: 23390011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of prostaglandin receptor EP1 expression involves its association with cyclooxygenase-2.
    Sood R; Flint-Ashtamker G; Borenstein D; Barki-Harrington L
    PLoS One; 2014; 9(3):e91018. PubMed ID: 24614038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin E2 receptor EP1 expression in vulvar cancer.
    Buchholz A; Vattai A; Fürst S; Vilsmaier T; Zati Zehni A; Steger A; Kuhn C; Schmoeckel E; Dannecker C; Mahner S; Jeschke U; Heidegger HH
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5369-5376. PubMed ID: 36436093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.
    Abe T; Kunz A; Shimamura M; Zhou P; Anrather J; Iadecola C
    J Cereb Blood Flow Metab; 2009 Jan; 29(1):66-72. PubMed ID: 18648380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hit-to-lead optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as a novel class of EP1 receptor antagonists.
    Atobe M; Naganuma K; Kawanishi M; Morimoto A; Kasahara K; Ohashi S; Suzuki H; Hayashi T; Miyoshi S
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6064-7. PubMed ID: 24094816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin E2 type 1 receptors contribute to neuronal apoptosis after transient forebrain ischemia.
    Shimamura M; Zhou P; Casolla B; Qian L; Capone C; Kurinami H; Iadecola C; Anrather J
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1207-14. PubMed ID: 23632967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of novel 1,2,3,6-tetrahydropyridyl-substituted benzo[d]thiazoles: Lead generation and optimization toward potent and orally active EP
    Umei K; Nishigaya Y; Tatani K; Kohno Y; Tanaka N; Seto S
    Bioorg Med Chem; 2017 Jul; 25(13):3406-3430. PubMed ID: 28483455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.
    Ma X; Kundu N; Ioffe OB; Goloubeva O; Konger R; Baquet C; Gimotty P; Reader J; Fulton AM
    Mol Cancer Res; 2010 Oct; 8(10):1310-8. PubMed ID: 20858737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor.
    Doré S
    Trends Pharmacol Sci; 2006 Sep; 27(9):458-60. PubMed ID: 16870271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin receptor EP₁-mediated differential degradation of cyclooxygenases involves a specific lysine residue.
    Spector-Chotiner A; Shraga-Heled N; Sood R; Rimon G; Barki-Harrington L
    Biochem Biophys Res Commun; 2014 Jan; 443(2):738-42. PubMed ID: 24333447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.